In this session, Chase McGrath, Aspirion’s VP of Product, delivers a data-driven look at AI automation in clinical appeals—examining how hospitals can close the speed gap with payers and recover legitimate revenue that’s stacking up in denial queues across DRG downgrades, medical necessity, and authorization denials.
By the end of this session, you’ll be able to:
- Apply a four-pillar readiness framework to assess your organization’s AI capability and prioritize the highest-impact denial types for automation
- Benchmark performance expectations using real-world overturn rates, time-to-resolution metrics, and ROI data across DRG, medical necessity, and authorization appeals
- Evaluate build, buy, and partnership strategies for AI implementation using decision criteria that align technology approach with organizational readiness and resource constraints
